Get started
Author

Sarah K. Brode

Observed names: Brode, Sarah, Brode, Sarah K, S. Brode, S. K. Brode, S.K. Brode, SARAH BRODE, Sarah K. Brode, Sarah Brode, Sarah K Brode, Sarah Kathleen Brode
Institutions: University Health Network, University of British Columbia, University of Toronto, University of Oxford, West Park Healthcare Centre, Research Institute of the McGill University Health Centre, McGill University
Observed institutions: Mount Sinai Hospital, Sunnybrook Health Science Centre, University Health Network, University of British Columbia, Oregon Health & Science University, University of Toronto, Toronto Western Hospital, Hospital for Sick Children, McGill University Health Centre, Toronto General Hospital, University of Oxford, Paratek Pharmaceuticals (United States), West Park Healthcare Centre, Public Health Ontario, Sinai Health System, Institute for Clinical Evaluative Sciences, Sunnybrook Hospital, Research Institute of the McGill University Health Centre, McGill University, University of Windsor
ORCID: 0000-0002-3855-6368
Observed ORCID: 0000-0002-3855-6368
OpenAlex ID: A5000293471
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
2018 · Nafees Ahmad, Shama D Ahuja, et al. · The Lancet · 633
Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis
2020 · Zhiyi Lan, Nafees Ahmad, et al. · The Lancet Respiratory Medicine · 269
The epidemiologic relationship between tuberculosis and non-tuberculous mycobacterial disease: a systematic review
2014 · S. K. Brode, C. L. Daley, et al. · The International Journal of Tuberculosis and Lung Disease · 225
Increased risk of mycobacterial infections associated with anti-rheumatic medications
2015 · S. K. Brode, F. B. Jamieson, et al. · Thorax · 167
PDF
The risk of mycobacterial infections associated with inhaled corticosteroid use
2017 · Sarah K. Brode, Michael A. Campitelli, et al. · European Respiratory Journal · 157
PDF
Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease: Figure 1:
2012 · Sarah K. Brode, Simon C. Ling, et al. · Canadian Medical Association Journal · 92
PDF
Pulmonary Nontuberculous Mycobacteria–Associated Deaths, Ontario, Canada, 2001–2013
2017 · Theodore K. Marras, Michael A. Campitelli, et al. · Emerging infectious diseases · 88
PDF
Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis
2019 · Syed Abidi, Jay Achar, et al. · European Respiratory Journal · 82
PDF
Pulmonary versus Nonpulmonary Nontuberculous Mycobacteria, Ontario, Canada
2017 · Sarah K. Brode, Alex Marchand-Austin, et al. · Emerging infectious diseases · 82
PDF
Risk of Mycobacterial Infections Associated With Rheumatoid Arthritis in Ontario, Canada
2014 · Sarah K. Brode, Frances B. Jamieson, et al. · CHEST Journal · 66
Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease
2023 · Connie A Haley, Marcos C Schechter, et al. · Clinical Infectious Diseases · 50
PDF
Risk of nontuberculous mycobacterial pulmonary disease with obstructive lung disease
2016 · Theodore K. Marras, Michael A. Campitelli, et al. · European Respiratory Journal · 40
PDF
Health‐related quality of life, comorbidities and mortality in pulmonary nontuberculous mycobacterial infections: A systematic review
2016 · Man Wah Yeung, Edwin Khoo, et al. · Respirology · 32
PDF
Population structure and divergence using microsatellite and gene locus markers in Chinook salmon (Oncorhynchus tshawytscha) populations
2006 · Daniel D Heath, J Mark Shrimpton, et al. · Canadian Journal of Fisheries and Aquatic Sciences · 32
Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in Toronto, Canada
2019 · Maria Luisa Aznar, Theodore K. Marras, et al. · BMC Pharmacology and Toxicology · 29
PDF
Dual therapy in IPAH and SSc-PAH. A qualitative systematic review
2012 · Sindhu R. Johnson, Sarah K. Brode, et al. · Respiratory Medicine · 29
PDF
Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB)
2021 · Natasha F. Sabur, Mantaj S. Brar, et al. · BMC Infectious Diseases · 26
PDF
Surgical Site Infection Affects Length of Stay After Complex Head and Neck Procedures
2020 · Nicole L. Lebo, Alexandra E. Quimby, et al. · The Laryngoscope · 25
Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010–2016
2022 · Jonathon R. Campbell, Placide Nsengiyumva, et al. · Emerging infectious diseases · 22
PDF
Patient-Reported Symptom and Health-Related Quality-of-Life Validation and Responsiveness During the First 6 Months of Treatment for Mycobacterium avium Complex Pulmonary Disease
2023 · Emily Henkle, Alexandra L. Quittner, et al. · CHEST Journal · 20
Identification of Barriers to Influenza Vaccination in Patients with Chronic Obstructive Pulmonary Disease: Analysis of the 2012 Behavioral Risk Factors Surveillance Survey
2016 · Douglas Hsu, Crystal North, et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · 20
PDF
Multidrug‐Resistant Tuberculosis: Treatment and Outcomes of 93 Patients
2015 · Sarah K Brode, Robert Varadi, et al. · Canadian Respiratory Journal · 20
PDF
Impact of COVID-19 on Tuberculosis Prevention and Treatment in Canada: A Multicenter Analysis of 10 833 Patients
2021 · Coralie Geric, Mariane Saroufim, et al. · The Journal of Infectious Diseases · 19
PDF
Evaluation of Mycobacterium Avium Complex Pulmonary Disease Treatment Completion and Adherence to ATS/IDSA Guidelines
2022 · Jennifer H Ku, Emily Henkle, et al. · Clinical Infectious Diseases · 18
Clinical outcomes in Mycobacterium xenopi versus Mycobacterium avium complex pulmonary disease: A retrospective matched cohort study
2020 · Ahmad Zaheen, Takashi Hirama, et al. · Respiratory Medicine · 18
PDF
Works count: 99
Citation count: 2,564
H-index: 20
I10-index: 36
Year
Topic
Type